Dioseve is a Tokyo-based biotech company developing innovative fertility treatments by applying iPS cell-derived ovarian technology. Its flagship product, DIOS-101, aims to dramatically improve in vitro maturation and expand fertility options for patients worldwide. Dioseve collaborates with leading clinics and research institutions to transform the future of reproductive medicine.
This is some text inside of a div block.
